Preparing for the Next Potential Pandemic-Chikungunya, Dengue, Zika and Other Viruses. [PDF]
Vajo Z, Laszlofy C.
europepmc +1 more source
Dengue, chikungunya and Zika virus surveillance in blood donors in Brazil, 2019–2021
Abstract Background and Objectives Arbovirus infections are a major public health concern in Brazil and an ongoing blood safety concern. Periodic outbreaks of such infections are common in the general population. This study aimed to establish the rates of dengue, chikungunya and Zika virus (DENV, CHIKV, ZIKV) RNAemia among blood donors at six public ...
Eduard Grebe +18 more
wiley +1 more source
Sensorial function in children with congenital Zika syndrome: what is the relationship with motor function? [PDF]
Brito ASS +6 more
europepmc +1 more source
Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium. [PDF]
Miranda-Filho DB +48 more
europepmc +1 more source
Proof-of-Concept Machine Learning Framework for Arboviral Disease Classification Using Literature-Derived Synthetic Data: Methodological Development Preceding Clinical Validation. [PDF]
Cruz-Parada E +16 more
europepmc +1 more source
Study on the spatiotemporal regulation of interferon-stimulated genes during Zika virus infection. [PDF]
Chen XZ +5 more
europepmc +1 more source
Comparison of human cerebral organoids infected with wild-type Zika versus attenuated DN-2 virus strains uncovers differences in host immune responses. [PDF]
Choo YY +5 more
europepmc +1 more source
Low-Cost Label-Free Electrochemical Aptasensor for Dual Detection of Dengue and Zika Using Fluorine-Doped Tin Oxide Modified with APTES and Gold Nanoparticles. [PDF]
Bachour Junior B +4 more
europepmc +1 more source
Outbreaks and incidence of vector-borne diseases in Colombia (2007-2024): Impact of climate change and deforestation [PDF]
Olivera MJ +2 more
europepmc +1 more source
Evaluation of Polymyxin B as a Novel Vaccine Adjuvant and Its Immunological Comparison with FDA-Approved Adjuvants. [PDF]
Gulani M +7 more
europepmc +1 more source

